Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study.
Castaman G, Rodeghiero F, Tosetto A, Cappelletti A, Baudo F, Eikenboom JC, Federici AB, Lethagen S, Linari S, Lusher J, Nishino M, Petrini P, Srivastava A, Ungerstedt JS.
Castaman G, et al. Among authors: baudo f.
J Thromb Haemost. 2006 Oct;4(10):2164-9. doi: 10.1111/j.1538-7836.2006.02070.x.
J Thromb Haemost. 2006.
PMID: 16999850
Free article.